Therefore, the activation of insulin signaling molecules in adipose tissue and fat cells to promote the translocation of intracellular GLUT4 to the cell membrane and to increase the uptake and consumption of glucose may be a new strategy for the treatment of T2DM [7]. The gene discussed is INS; the disease is type 2 diabetes mellitus.